IRIS Accounts Production v24.1.0.578 02266184 Board of Directors 1.2.23 31.1.24 31.1.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh022661842023-01-31022661842024-01-31022661842023-02-012024-01-31022661842022-01-31022661842022-02-012023-01-31022661842023-01-3102266184ns15:EnglandWales2023-02-012024-01-3102266184ns14:PoundSterling2023-02-012024-01-3102266184ns10:Director12023-02-012024-01-3102266184ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3102266184ns10:SmallEntities2023-02-012024-01-3102266184ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3102266184ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3102266184ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3102266184ns10:FullAccounts2023-02-012024-01-3102266184ns10:Director22023-02-012024-01-3102266184ns10:RegisteredOffice2023-02-012024-01-3102266184ns5:CurrentFinancialInstruments2024-01-3102266184ns5:CurrentFinancialInstruments2023-01-3102266184ns5:ShareCapital2024-01-3102266184ns5:ShareCapital2023-01-3102266184ns5:CapitalRedemptionReserve2024-01-3102266184ns5:CapitalRedemptionReserve2023-01-3102266184ns5:RetainedEarningsAccumulatedLosses2024-01-3102266184ns5:RetainedEarningsAccumulatedLosses2023-01-3102266184ns5:PlantMachinery2023-02-012024-01-3102266184ns5:PlantMachinery2023-01-3102266184ns5:PlantMachinery2024-01-3102266184ns5:PlantMachinery2023-01-3102266184ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-3102266184ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-3102266184ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2024-01-3102266184ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2023-01-31
REGISTERED NUMBER: 02266184 (England and Wales)









UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 JANUARY 2024

FOR

KENNET BIOSERVICES LIMITED

KENNET BIOSERVICES LIMITED (REGISTERED NUMBER: 02266184)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 January 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


KENNET BIOSERVICES LIMITED

COMPANY INFORMATION
for the year ended 31 January 2024







DIRECTORS: G Prout
W A Prout



REGISTERED OFFICE: Swatton Barn
Badbury
Swindon
Wiltshire
SN4 0EU



REGISTERED NUMBER: 02266184 (England and Wales)



ACCOUNTANTS: d&t
Chartered Accountants
Swatton Barn
Badbury
Swindon
Wiltshire
SN4 0EU



BANKERS: HSBC Plc
Unit 6
The Lock
Canal Walk
Swindon
Wiltshire
SN1 1LD

KENNET BIOSERVICES LIMITED (REGISTERED NUMBER: 02266184)

BALANCE SHEET
31 January 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,728 3,487

CURRENT ASSETS
Debtors 5 39,418 30,177
Cash at bank 168,701 169,567
208,119 199,744
CREDITORS
Amounts falling due within one year 6 24,493 25,080
NET CURRENT ASSETS 183,626 174,664
TOTAL ASSETS LESS CURRENT
LIABILITIES

186,354

178,151

PROVISIONS FOR LIABILITIES 518 663
NET ASSETS 185,836 177,488

CAPITAL AND RESERVES
Called up share capital 222 222
Capital redemption reserve 378 378
Retained earnings 185,236 176,888
SHAREHOLDERS' FUNDS 185,836 177,488

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

KENNET BIOSERVICES LIMITED (REGISTERED NUMBER: 02266184)

BALANCE SHEET - continued
31 January 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 April 2024 and were signed on its behalf by:





G Prout - Director


KENNET BIOSERVICES LIMITED (REGISTERED NUMBER: 02266184)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 January 2024

1. STATUTORY INFORMATION

Kennet Bioservices Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% straight line basis and 15% straight line basis

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

HIRE PURCHASE AND LEASING COMMITMENTS
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

KENNET BIOSERVICES LIMITED (REGISTERED NUMBER: 02266184)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 January 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2023 - 4 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 February 2023 56,096
Additions 707
At 31 January 2024 56,803
DEPRECIATION
At 1 February 2023 52,609
Charge for year 1,466
At 31 January 2024 54,075
NET BOOK VALUE
At 31 January 2024 2,728
At 31 January 2023 3,487

5. DEBTORS
2024 2023
£    £   
Amounts falling due within one year:
Trade debtors 34,486 22,928
Other debtors 3,232 5,549
37,718 28,477

Amounts falling due after more than one year:
Other debtors 1,700 1,700

Aggregate amounts 39,418 30,177

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors - 13,735
Taxation and social security 23,778 6,822
Other creditors 715 4,523
24,493 25,080

7. LEASING AGREEMENTS
At 31 January 2024, the company had total commitments under non-cancellable operating leases over the remaining life of those leases of £4,862 (2023 : £13,562).

KENNET BIOSERVICES LIMITED (REGISTERED NUMBER: 02266184)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 January 2024

8. RELATED PARTY DISCLOSURES

Unless otherwise disclosed, all related party transactions have been conducted under normal market
conditions, including dividend payments to it's shareholders.